83 FR 8482 - Meeting of the National Advisory Council for Healthcare Research and Quality
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality Federal Register Volume 83, Issue 39 (February 27, 2018)
Agency for Healthcare Research and Quality
Federal Register Volume 83, Issue 39 (February 27, 2018)
| Page Range | 8482-8482 | |
| FR Document | 2018-03926 |
[Federal Register Volume 83, Number 39 (Tuesday, February 27, 2018)] [Notices] [Page 8482] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-03926] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Meeting of the National Advisory Council for Healthcare Research and Quality AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of public meeting. ----------------------------------------------------------------------- SUMMARY: This notice announces a meeting of the National Advisory Council for Healthcare Research and Quality. DATES: The meeting will be held on Friday, March 16, 2018, from 11:00 a.m. to 1:00 p.m. (EST). ADDRESSES: The meeting will be held virtually (via WebEx). FOR FURTHER INFORMATION CONTACT: Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427- 1456. For press-related information, please contact Alison Hunt at (301) 427-1244 or at [email protected]. Closed captioning will be provided during the WebEx. If another accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827- 4840, no later than Friday, March 9, 2018. SUPPLEMENTARY INFORMATION: I. Purpose The National Advisory Council for Healthcare Research and Quality is authorized by Section 941 of the Public Health Service Act, 42 U.S.C. 299c. In accordance with its statutory mandate, the Council is to advise the Secretary of the Department of Health and Human Services and the Director of AHRQ on matters related to AHRQ's conduct of its mission including providing guidance on (A) priorities for health care research, (B) the field of health care research including training needs and information dissemination on health care quality and (C) the role of the Agency in light of private sector activity and opportunities for public private partnerships. The Council is composed of members of the public, appointed by the Secretary, and Federal ex- officio members specified in the authorizing legislation. II. Agenda On Friday, March 16, 2018, the Council meeting will convene via WebEx at 11:00 a.m. (EST), with the call to order by the Council Chair and approval of previous Council summary notes. The agenda will include an update by the AHRQ Director and an update on the Healthcare Cost and Utilization Project (HCUP) new release of county level statistics on hospital stays for alcohol, opioids, and other drugs. The meeting is open to the public. For information regarding how to access the WebEx as well as other meeting details, please go to https://www.ahrq.gov/news/events/nac/. Karen J. Migdail, Chief of Staff. [FR Doc. 2018-03926 Filed 2-26-18; 8:45 am] BILLING CODE 4160-90-P
![8482 Federal Register / Vol. 83, No. 39 / Tuesday, February 27, 2018 / Notices
B. What are the equipment parameters II. Hospitalization Rockville, Maryland, 20857, (301) 427–
that are necessary to achieve desired III. Admission/readmission to intensive 1456. For press-related information,
outcomes (e.g. flow capabilities, care unit (ICU) please contact Alison Hunt at (301) 427–
settings, etc.)? IV. Need for intubation 1244 or at Alison.Hunt@ahrq.hhs.gov.
C. What are the parameters of V. Outpatient visits Closed captioning will be provided
prescribed patient usage (e.g. frequency VI. Emergency room visits during the WebEx. If another
of use, duration of use throughout the VII. Disease exacerbations accommodation for a disability is
day, other)? VIII. Quality of life (QoL)
IX. Activities of daily living (ADL) needed, please contact the Food and
D. In each of the above populations,
X. Dyspnea Drug Administration (FDA) Office of
what are the parameters of patient
compliance with the prescribed usage of XI. Sleep quality Equal Employment Opportunity and
the equipment? XII. Exercise tolerance Diversity Management on (301) 827–
IV. What respiratory services, other XIII. Adverse events 4840, no later than Friday, March 9,
than the technical support of the use of 2018.
Timing
the prescribed equipment, are being
I. At least 1 month of treatment SUPPLEMENTARY INFORMATION:
provided to the above patients in the
home (e.g. patient education, ongoing Setting I. Purpose
smoking cessation, respiratory therapist
led home care)? I. Home The National Advisory Council for
V. What are the professional II. Assisted living residence Healthcare Research and Quality is
guidelines and statements which Publication Time authorized by Section 941 of the Public
address KQ 1 to KQ 4? Health Service Act, 42 U.S.C. 299c. In
I. From 1995
accordance with its statutory mandate,
PICOTS (Populations, Interventions,
Subgroup Analysis the Council is to advise the Secretary of
Comparators, Outcomes, Timing,
Settings) I. Type of diseases the Department of Health and Human
A. Neuromuscular diseases Services and the Director of AHRQ on
Population(s) B. Thoracic restrictive diseases matters related to AHRQ’s conduct of its
I. Adults 18 years and older with i. Thoracic cage abnormalities mission including providing guidance
chronic respiratory failure due to: ii. Morbid obesity on (A) priorities for health care research,
A. Neuromuscular diseases C. COPD (B) the field of health care research
B. Thoracic restrictive diseases D. Other lung diseases (cystic fibrosis, including training needs and
(including thoracic cage bronchiectasis) information dissemination on health
abnormalities and morbid obesity) II. Length of treatment (1 month, 3 care quality and (C) the role of the
C. Chronic obstructive pulmonary months, 6 months and longer) Agency in light of private sector activity
disease
D. Other lung diseases (cystic fibrosis, Karen J. Migdail, and opportunities for public private
bronchiectasis) Chief of Staff. partnerships. The Council is composed
[FR Doc. 2018–03927 Filed 2–26–18; 8:45 am] of members of the public, appointed by
Interventions the Secretary, and Federal ex-officio
BILLING CODE 4160–90–P
I. Home mechanical ventilators (FDA- members specified in the authorizing
approved only) with or without legislation.
pertinent ancillary in-home services DEPARTMENT OF HEALTH AND
II. Agenda
(e.g. respiratory therapy in the HUMAN SERVICES
home; pharmacy reconciliation; On Friday, March 16, 2018, the
smoking cessation, etc.) Agency for Healthcare Research and Council meeting will convene via
II. BPAP respiratory assist devices Quality
WebEx at 11:00 a.m. (EST), with the call
(FDA-approved only) w/or w/o
Meeting of the National Advisory to order by the Council Chair and
pertinent ancillary in-home services
III. CPAP respiratory assist devices Council for Healthcare Research and approval of previous Council summary
(FDA-approved only) w/or w/o Quality notes. The agenda will include an
pertinent ancillary in-home services update by the AHRQ Director and an
AGENCY: Agency for Healthcare Research update on the Healthcare Cost and
Comparators and Quality (AHRQ), HHS. Utilization Project (HCUP) new release
I. Usual care (i.e. no mechanical ACTION: Notice of public meeting. of county level statistics on hospital
ventilation/BPAP/CPAP) stays for alcohol, opioids, and other
SUMMARY: This notice announces a
II. Different type of noninvasive drugs. The meeting is open to the
meeting of the National Advisory
mechanical ventilation public. For information regarding how
III. Different modes of same equipment Council for Healthcare Research and
Quality. to access the WebEx as well as other
IV. Other noninvasive ventilation meeting details, please go to https://
(Studies without a comparator DATES: The meeting will be held on www.ahrq.gov/news/events/nac/.
treatment that evaluate the effect of a Friday, March 16, 2018, from 11:00 a.m.
patient characteristic, laboratory to 1:00 p.m. (EST). Karen J. Migdail,
daltland on DSKBBV9HB2PROD with NOTICES
criteria, ventilator parameter, or ADDRESSES: The meeting will be held Chief of Staff.
respiratory services on outcomes of virtually (via WebEx). [FR Doc. 2018–03926 Filed 2–26–18; 8:45 am]
interest will be included) FOR FURTHER INFORMATION CONTACT: BILLING CODE 4160–90–P
Outcomes Jaime Zimmerman, Designated
Management Official, at the Agency for
Patient-Centered Outcomes Healthcare Research and Quality, 5600
I. Mortality Fishers Lane, Mail Stop 06E37A,
VerDate Sep<11>2014 19:49 Feb 26, 2018 Jkt 244001 PO 00000 Frm 00065 Fmt 4703 Sfmt 9990 E:\FR\FM\27FEN1.SGM 27FEN1](https://thefederalregister.org/doc/83_FR_8521/page/1.svg)
Document Created: 2018-02-27 01:14:44
Document Modified: 2018-02-27 01:14:44
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of public meeting. | |
| Dates | The meeting will be held on Friday, March 16, 2018, from 11:00 a.m. to 1:00 p.m. (EST). | |
| Contact | Jaime Zimmerman, Designated Management Official, at the Agency for Healthcare Research and Quality, 5600 Fishers Lane, Mail Stop 06E37A, Rockville, Maryland, 20857, (301) 427- 1456. For press-related information, please contact Alison Hunt at (301) 427-1244 or at [email protected] Closed captioning will be provided during the WebEx. If another accommodation for a disability is needed, please contact the Food and Drug Administration (FDA) Office of Equal Employment Opportunity and Diversity Management on (301) 827- 4840, no later than Friday, March 9, 2018. | |
| FR Citation | 83 FR 8482 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR